Chronic Myeloid Leukemia
This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls o...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2021, 2021
|
| Edition: | 2nd ed. 2021 |
| Series: | Hematologic Malignancies
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Cytogenetics of Chronic Myeloid Leukemia (CML)
- The Biology and Pathogenesis of Chronic Myeloid Leukaemia
- Epidemiology of Chronic Myeloid Leukemia.-Imatinib and the first line CML Therapy
- CML Therapy: A Focus on Second and Third Generation Tyrosine Kinase Inhibitors
- Adverse events associated with ATP-competitive BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
- Pharmacoeconomic considerations for tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
- Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update
- Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death
- A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia
- The Role of Hematopoietic Stem Cell Transplantation in CML
- CML end-phase and blast crisis: implications and management
- The Interferon-alpha Revival in CML
- Managing Pregnancy in Chronic Myeloid Leukemia
- Response-Related Predictors of Survival and of Treatment Free Remission in CML
- Discontinuation or cessation of tyrosine kinase inhibitor treatment in Chronic myeloid leukemia patients with deep molecular response.